ConductScience.org, home

Paper · 31754328

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120,981,101The patterns and dynamics of genomic instability in metastatic pancreatic cancer.Nature2010https://conductscience.org/library/papers/20981101PubMed
212,509,765Targeting tumours with genetically enhanced T lymphocytes.Nat Rev Cancer2003https://conductscience.org/library/papers/12509765PubMed
312,427,307Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.Hum Gene Ther2002https://conductscience.org/library/papers/12427307PubMed
429,880,908Driving cars to the clinic for solid tumors.Gene Ther2018https://conductscience.org/library/papers/29880908PubMed
524,876,563Current concepts in the diagnosis and management of cytokine release syndrome.Blood2014https://conductscience.org/library/papers/24876563PubMed
618,559,619Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers.Clin Cancer Res2008https://conductscience.org/library/papers/18559619PubMed
728,405,515PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells.Oncoimmunology2017https://conductscience.org/library/papers/28405515PubMed
817,108,138CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.Cancer Res2006https://conductscience.org/library/papers/17108138PubMed
927,009,301Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China.Sci China Life Sci2016https://conductscience.org/library/papers/27009301PubMed
1028,929,447Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells.Protein Cell2017https://conductscience.org/library/papers/28929447PubMed
1126,110,321Seatbelts in CAR therapy: How Safe Are CARS?Pharmaceuticals (Basel)2015https://conductscience.org/library/papers/26110321PubMed
1223,839,099TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy.Mol Ther Nucleic Acids2013https://conductscience.org/library/papers/23839099PubMed
1327,145,284Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model.Oncotarget2016https://conductscience.org/library/papers/27145284PubMed
1423,939,024Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.Mol Ther2013https://conductscience.org/library/papers/23939024PubMed
1518,767,947EGF receptor variant III as a target antigen for tumor immunotherapy.Expert Rev Vaccines2008https://conductscience.org/library/papers/18767947PubMed
1619,384,291Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.Mol Ther2009https://conductscience.org/library/papers/19384291PubMed
1724,409,448Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo.Cancer Immunol Res2013https://conductscience.org/library/papers/24409448PubMed
1829,104,305Full-length antibodies versus single-chain antibody fragments for a selective impedimetric lectin-based glycoprofiling of prostate specific antigen.Electrochim Acta2017https://conductscience.org/library/papers/29104305PubMed
1926,330,164Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity.Cancer Res2015https://conductscience.org/library/papers/26330164PubMed
2024,277,834Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24277834PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/31754328/references